Cite

HARVARD Citation

    del Regno, L. et al. (2020). Clinical significance of BRAF/NRAS concurrent mutations in a clinic‐based metastatic melanoma cohort. British journal of dermatology. pp. 1281-1283. [Online]. 
  
Back to record